SN-38, a metabolite of the camptothecin derivative CPT-11, potentiates the cytotoxic effect of radiation in human colon adenocarcinoma cells grown as spheroids

This publication has 14 references indexed in Scilit:

• Drug and radiation resistance in spheroids: cell contact and kinetics
  Cancer and Metastasis Reviews, 1994
• Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group.
  Journal of Clinical Oncology, 1993
• Hyperthermic enhancement of cell killing by five platinum complexes in human malignant melanoma cells grown as monolayer cultures and multicellular spheroids
  International Journal of Radiation Oncology*Biology*Physics, 1993
• Posttreatment exposure to camptothecin enhances the lethal effects of x-rays on radioresistant human malignant melanoma cells
  International Journal of Radiation Oncology*Biology*Physics, 1992
• Camptothecin analog (CPT-11)-sensitive human pancreatic tumor cell line QGP-1N shows resistance to SN-38, an active metabolite of CPT-11
  Biochemical and Biophysical Research Communications, 1992
• A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.
  Journal of Clinical Oncology, 1992
• DNA Damaging and Cell Cycle Effects of the Topoisomerase I Poison Camptothecin in Irradiated Human Cells
  International Journal of Radiation Biology, 1992
• Potentiation of radiation response in human carcinoma cells in vitro and murine fibrosarcoma in vivo by topotecan, an inhibitor of DNA topoisomerase I
  International Journal of Radiation Oncology*Biology*Physics, 1992
• Radiation respones of HMV-I human malignant melanoma cells grown in vitro as multicellular spheroids.
  Journal of Radiation Research, 1983
• Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation
  International Journal of Cancer, 1983